Cercle
Andreas Melder has extensive experience in various leadership roles and advisory positions in the technology industry. Currently, they are the Co-Founder and Board Member of Cercle, an AI technology company focused on advancing healthcare for women. Andreas is also a Board Member of Peraso Inc., a company that specializes in wireless technology.
In the past, Andreas has served as a Board Advisor for Glass Media, a retail marketing experience provider, and Motus Labs, a company that designs motion control solutions for automation and robotics applications.
Andreas has also worked as an Advisor for SmartMoving Software, a company specializing in software and CRM systems for moving companies. During their time at SmartMoving, the company was acquired due to its strong leadership and high-growth profile.
Andreas has held roles at Broadcom Inc. as part of the LATAM Operator Marketing team and at Vilynx as a Board Advisor. At Broadcom, they were responsible for developing and expanding the LATAM market for the Broadband Business Unit.
Prior to that, Andreas was the VP of Business Development at Gigle Networks, where they drove the company's strategy and played a key role in its acquisition by Broadcom. Andreas also served as the VP of Marketing at Prodea Systems, a company that developed a unique Service Operations Center for the Service Provider industry.
Throughout their career, Andreas has demonstrated expertise in technology, marketing, and business development, contributing to the growth and success of the companies they have worked with.
Andreas Melder completed their Bachelor of Science degree in Electrical Engineering & Business from Carnegie Mellon University between 1976 and 1980. Andreas then pursued a Master of Science degree in Digital Signal Processing & Operations Research/Business from Southern Methodist University from 1981 to 1983. Prior to their college education, Andreas attended Shaler Area High School from 1973 to 1976. Andreas later continued their education at Southern Methodist University, obtaining a Master's degree in Operations Research with a focus on Digital Signal Processing.
Cercle
Cercle is an AI technology company with the mission to advance healthcare for all women. With AI, we harness anonymized, diverse and reliable biomedical and genomics data from around the world to deliver unprecedented and secure healthcare insights. The Cercle™ Biomedical Graph is a first-of-its-kind knowledge graph. It uses AI to analyze billions of anonymized data points securely drawn from hospitals, clinics and research labs from all over the globe. We’re turning raw, unstructured and disconnected biomedical and genomics data into clear insights for doctors, hospitals, research centers, pharmaceutical companies, labs and clinics so they can treat patients more effectively. That’s how we support innovation and advancements in treatments and healthcare outcomes across the entire healthcare ecosystem. Women's health is the most underserved healthcare market, which is why Cercle's first focus will be fertility and IVF. We’re proud to beta launch Luce, a fertility companion for women and doctors that analyzes data from thousands of treatment cycles to help people make more informed decisions for their fertility journeys. Cercle’s suite of products includes: — Data access tools: Researchers and lab directors can query and visualize structured biomedical and genomics data to accelerate health innovation. — Modeling and insights products: Advanced modeling tools help healthcare providers with financial and operational strategies. — Tools for clinicians: Doctors get personalized care insights and predictive treatment outcomes based on Real World Data and Real World Evidence. — Patient companions: Patients get clear, data-driven insights that make it easier to understand their health and make informed decisions with their doctors. Cercle is built by medical professionals, molecular biologists, data scientists, engineers and business entrepreneurs dedicated to unlocking a world where everyone feels informed, empowered, and in control of their own health.